• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国人群中糖尿病风险因素与肝脂肪变性的联合研究:中国心脏代谢风险(CRC)研究

Combination of diabetes risk factors and hepatic steatosis in Chinese: the Cardiometabolic Risk in Chinese (CRC) Study.

作者信息

Liang Jun, Wang Yu, Li Hongyan, Liu Xuekui, Qiu Qinqin, Qi Lu

机构信息

Department of Endocrinology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical College, Xuzhou Institute of Medical Sciences, Xuzhou Institute of Diabetes, Affiliated Hospital of Southeast University, Xuzhou, Jiangsu, China.

Xuzhou Medical College, Xuzhou, Jiangsu, China.

出版信息

PLoS One. 2014 Mar 3;9(3):e90101. doi: 10.1371/journal.pone.0090101. eCollection 2014.

DOI:10.1371/journal.pone.0090101
PMID:24595017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3940820/
Abstract

AIMS

Hepatic steatosis has been related to insulin resistance and increased diabetes risk. We assessed whether combination of diabetes risk factors, evaluated by the Finnish Diabetes Risk Score, was associated with risk of hepatic steatosis in an apparently healthy Chinese population.

RESEARCH DESIGN AND METHODS

The study samples were from a community-based health examination survey in central China. In total 1,780 men and women (18-64 y) were included in the final analyses. Hepatic steatosis was diagnosed by ultrasonography. We created combination of diabetes risk factors score on basis of age, Body Mass Index, waist circumference, physical activity at least 4 h a week, daily consumption of fruits, berries or vegetables, history of antihypertensive drug treatment, history of high blood glucose. The total risk score is a simple sum of the individual weights, and values range from 0 to 20.

RESULTS

Hepatic steatosis was present 18% in the total population. In multivariate models, the odds ratios of hepatic steatosis were 1.20 (95%CI 1.15-1.25) in men and 1.25 (95%CI 1.14-1.37) in women by each unit increase in the combination of diabetes risk factors score, after adjustment for blood pressure, liver enzymes, plasma lipids, and fasting glucose. The area under the receiver operating characteristic curve for hepatic steatosis was 0.78 (95%CI 0.76-0.80), 0.76 in men (95%CI 0.74-0.78) and 0.83 (95%CI 0.79-0.87) in women.

CONCLUSIONS

Our data suggest that combination of major diabetes risk factors was significantly related to risk of hepatic steatosis in Chinese adults.

摘要

目的

肝脂肪变性与胰岛素抵抗及糖尿病风险增加有关。我们评估了通过芬兰糖尿病风险评分评估的糖尿病风险因素组合是否与明显健康的中国人群的肝脂肪变性风险相关。

研究设计与方法

研究样本来自中国中部一项基于社区的健康检查调查。最终分析纳入了1780名男性和女性(18 - 64岁)。通过超声检查诊断肝脂肪变性。我们根据年龄、体重指数、腰围、每周至少4小时的身体活动、每日水果、浆果或蔬菜的摄入量、抗高血压药物治疗史、高血糖病史创建了糖尿病风险因素组合评分。总风险评分是各个权重的简单相加,取值范围为0至20。

结果

总体人群中肝脂肪变性的发生率为18%。在多变量模型中,在校正血压、肝酶、血脂和空腹血糖后,糖尿病风险因素组合评分每增加一个单位,男性肝脂肪变性的优势比为1.20(95%置信区间1.15 - 1.25),女性为1.25(95%置信区间1.14 - 1.37)。肝脂肪变性的受试者工作特征曲线下面积为0.78(95%置信区间0.76 - 0.80),男性为0.76(95%置信区间0.74 - 0.78),女性为0.83(95%置信区间0.79 - 0.87)。

结论

我们的数据表明,主要糖尿病风险因素的组合与中国成年人的肝脂肪变性风险显著相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c568/3940820/465b5da0b5d1/pone.0090101.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c568/3940820/465b5da0b5d1/pone.0090101.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c568/3940820/465b5da0b5d1/pone.0090101.g001.jpg

相似文献

1
Combination of diabetes risk factors and hepatic steatosis in Chinese: the Cardiometabolic Risk in Chinese (CRC) Study.中国人群中糖尿病风险因素与肝脂肪变性的联合研究:中国心脏代谢风险(CRC)研究
PLoS One. 2014 Mar 3;9(3):e90101. doi: 10.1371/journal.pone.0090101. eCollection 2014.
2
The Finnish Diabetes Risk Score (FINDRISC) as a screening tool for hepatic steatosis.芬兰糖尿病风险评分(FINDRISC)作为肝脂肪变性的筛查工具。
Ann Med. 2011;43(6):487-94. doi: 10.3109/07853890.2011.554428. Epub 2011 May 23.
3
Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.非肥胖绝经后女性血清尿酸水平与肝脂肪变性的关系。
Climacteric. 2014 Dec;17(6):692-9. doi: 10.3109/13697137.2014.926323. Epub 2014 Aug 7.
4
The combined effects of alcohol consumption and body mass index on hepatic steatosis in a general population sample of European men and women.在欧洲男性和女性的一般人群样本中,酒精摄入量和体重指数对肝脂肪变性的综合影响。
Aliment Pharmacol Ther. 2015 Mar;41(5):467-76. doi: 10.1111/apt.13067. Epub 2015 Jan 15.
5
Waist-to-calf circumstance ratio is an independent predictor of hepatic steatosis and fibrosis in patients with type 2 diabetes.腰臀比是 2 型糖尿病患者肝脂肪变性和纤维化的独立预测因子。
J Gastroenterol Hepatol. 2018 May;33(5):1082-1091. doi: 10.1111/jgh.14011. Epub 2018 Feb 6.
6
Utility of different indices in screening Chinese postmenopausal women for hepatic steatosis.不同指标在筛查中国绝经后女性肝脂肪变性中的效用。
Asia Pac J Clin Nutr. 2019;28(1):23-30. doi: 10.6133/apjcn.201903_28(1).0004.
7
Hepatic steatosis in obese Chinese children.肥胖中国儿童的肝脂肪变性
Int J Obes Relat Metab Disord. 2004 Oct;28(10):1257-63. doi: 10.1038/sj.ijo.0802734.
8
A simple clinical model predicts incident hepatic steatosis in a community-based cohort: The Framingham Heart Study.一种简单的临床模型可预测基于社区人群的肝脂肪变性事件:弗雷明汉心脏研究。
Liver Int. 2018 Aug;38(8):1495-1503. doi: 10.1111/liv.13709. Epub 2018 Mar 12.
9
Hepatic Steatosis: CT-Based Prevalence in Adults in China and the United States and Associations With Age, Sex, and Body Mass Index.肝脂肪变性:基于CT的中美成年人患病率及其与年龄、性别和体重指数的关联
AJR Am J Roentgenol. 2022 May;218(5):846-857. doi: 10.2214/AJR.21.26728. Epub 2021 Nov 24.
10
Insulin resistance and hepatic steatosis in type 1 diabetes mellitus and their association with diabetic chronic complications.1 型糖尿病中的胰岛素抵抗和肝脂肪变性及其与糖尿病慢性并发症的关系。
Minerva Endocrinol (Torino). 2023 Mar;48(1):27-34. doi: 10.23736/S2724-6507.20.03290-3. Epub 2020 Oct 2.

引用本文的文献

1
Neck circumference and prehypertension: the cardiometabolic risk in Chinese study.颈围与高血压前期:中国研究中的心脏代谢风险
J Hypertens. 2015 Feb;33(2):275-8. doi: 10.1097/HJH.0000000000000396.

本文引用的文献

1
Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies.中国大陆非酒精性脂肪性肝病的患病率:已发表研究的荟萃分析。
J Gastroenterol Hepatol. 2014 Jan;29(1):42-51. doi: 10.1111/jgh.12428.
2
Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis.超声检查诊断脂肪肝的准确性和可靠性:一项荟萃分析。
Hepatology. 2011 Sep 2;54(3):1082-1090. doi: 10.1002/hep.24452.
3
The Finnish Diabetes Risk Score (FINDRISC) as a screening tool for hepatic steatosis.
芬兰糖尿病风险评分(FINDRISC)作为肝脂肪变性的筛查工具。
Ann Med. 2011;43(6):487-94. doi: 10.3109/07853890.2011.554428. Epub 2011 May 23.
4
The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis.超声、CT、MRI 和 1H-MRS 检测肝脂肪变与肝活检对照的诊断准确性:荟萃分析。
Eur Radiol. 2011 Jan;21(1):87-97. doi: 10.1007/s00330-010-1905-5. Epub 2010 Jul 31.
5
Insulin resistance in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中的胰岛素抵抗。
Curr Pharm Des. 2010 Jun;16(17):1941-51. doi: 10.2174/138161210791208875.
6
Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD).非酒精性脂肪性肝病(NAFLD)的流行病学与自然史
Ann Hepatol. 2009;8 Suppl 1:S4-8.
7
NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.非酒精性脂肪性肝病作为糖尿病和代谢综合征发生的危险因素:一项为期11年的随访研究。
Am J Gastroenterol. 2009 Apr;104(4):861-7. doi: 10.1038/ajg.2009.67. Epub 2009 Mar 17.
8
The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type 2 diabetes.芬兰糖尿病风险评分与胰岛素抵抗及向2型糖尿病的进展相关。
J Clin Endocrinol Metab. 2009 Mar;94(3):920-6. doi: 10.1210/jc.2007-2427. Epub 2008 Dec 23.
9
Epidemiology of non-alcoholic fatty liver disease in China.中国非酒精性脂肪性肝病的流行病学
J Hepatol. 2009 Jan;50(1):204-10. doi: 10.1016/j.jhep.2008.10.010. Epub 2008 Nov 6.
10
Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations.非酒精性脂肪性肝病:患病率、诊断、发病机制及治疗考量概述
Clin Sci (Lond). 2008 Sep;115(5):141-50. doi: 10.1042/CS20070402.